Close

Oculus Innovative Sciences (OCLS) Granted FDA 510(K) Approval for Microcyn Plus Wound Care Solution

August 22, 2016 5:08 PM EDT Send to a Friend
Oculus Innovative Sciences (NASDAQ: OCLS) was granted FDA 510 (k) okay for its Microcyn ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login